CONTENTS: 1. Animal Biotechnology: An Overview; PART-I. DNA Technology: 2. Recombinant DNA and Gene Cloning: 1. Cloning and Expression Vectors; 3. Recombinant DNA and Gene Cloning: 2. Restriction Enzymes, Restriction Mapping, Chimeric DNA, Molecular Probes and Gene Libraries; 4. PCR, and Microarrays  (Including qRT-PCR and RACE-PCR);   5. Isolation and Synthesis of Genes/Genomes (Including ‘Synthetic Genomics’);   6. DNA-Based Molecular Markers; 7. DNA Sequencing Technologies (Including Next Generation Sequencing Methods); 8. DNA Fingerprinting and DNA Barcoding; 9. Genomics, Transcriptomics, Proteomics and Metabolomics; 10. Bioinformatics, In Silico Biology and Systems Biology; PART-II. Cell, Tissue and Organ Culture; Tissue Engineering, IVF and Cloning; 11. Animal Cell and Tissue Culture 1. Laboratory Facilities, Culture Media and Procedures; 12. Animal Cell and Tissue Culture 2. Primary Culture and Cell Lines; 13. Animal Cell and Tissue Culture 3. The Stem Cells; 14. Animal Cell and Tissue Culture 4. Primary Explantation Techniques: Tissue and Organ/Embryo Culture; 15. Tissue Engineering and Electrophysiology; 16. In Vitro Fertilization, Artificial Insemination and Embryo Transfer; 17. Cloning of Animals: Methods and Utility. PART-III. Gene Transfer/Targeting, Transgenic Animals, Biosafety and Drug Discovery/Designing; 18. Transfection Methods, Gene Targeting and Transgenic Animals; 19. Regulatory System for GE Animals: Biosafety and Ethical Issues; 20. Drug Discovery and Drug Designing (Including the Use of Microbial Genomics and  Development of ‘Genomic’ Drugs); PART-IV. Biotechnology in Medicine; 21. Immunology 1. B-Cells and Antibodies (Immunoglobulins); 22. Immunology 2. T-Cells, T-Cell Receptors and MHC Restriction; 23. Immunology 3. Hybridoma Technology and Monoclonal Antibodies (mAbs); 24. Vaccines, Diagnostics and Forensics; 25. HIV, AIDS and Biotechnology; 26. Gene Therapy; 27. Pharmacogenetics, Pharmacogenomics and  Personalized Medicine; 28. Regenerative Medicine; 29. Translational Medicine (Including Precision Medicine); 30. Oncogenes, Tumour Suppressor Genes, Tumour Viruses and Oncogenesis; PART-V. Animal Cytogenetics, QTL Analysis and Association Mapping; 31. Animal Cytogenetics and Genome Imprinting  (Including Human Cytogenetics); 32. Linkage-Based Genetics of Simple and Complex Human Disorders (Including QTL Analysis); 33. QTL Mapping for Complex Traits in Laboratory/Domestic Animals; 34. Linkage Disequilibrium (LD) & Association Mapping; PART-VI. Animal Genomics (Including Molecular  Maps and Whole Genome Sequencing); 35. Molecular Maps of Human and Animal Genomes 1. Methods for Construction of Maps; 36. Molecular Maps of Human and Other Animal Genomes 2. Available Molecular Maps; 37. Human Genome; 38. Non-Human Animal Genomes ; 39. Microbiome and Metagenome of Human and Other Mammals; PART-VII. Functional Genomics: 40. Methods for Genome Annotations and Identification of Genes; 41. Annotation of Genes: Reverse Genetics and Mutagenesis (Insertions, Deletions, RNAi, Nucleases and Knock-Outs); 42. Chemical Genetics/Genomics and Optogenetics; 43. Transcriptomics and ENCODE; 44. Proteomics and Metabolomics; PART-VIII. Other Areas of Animal Biotechnology: 45. Aquatic Ecosystem, Aquaculture and Aquatic Biotechnology: Blue Revolution; 46. Leather Industry and Animal Biotechnology; 47. Apoptosis and Animal Biotechnology; 48. Nanotechnology for Medicine and Animal Production; 49. Animal Biodiversity and Animal Genetic Resources (AnGR); 50. Intellectual Property Rights (IPRs) and Animal Biotechnology;  References; Index.